A Study to Compare the Effects of Two Anti-HIV Drug Combinations on the Immune Systems of HIV-Infected Patients

• Status: Completed
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to examine how the immune systems of HIV-infected patients react to 2 anti-HIV drug combinations.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Hoffmann-La Roche
• Treatments: Efavirenz; Ritonavir; Saquinavir

Criteria

Inclusion Criteria

Patients may be eligible for this study if they:

• Are HIV-positive.

• Have a viral load of at least 5,000 copies/ml and a CD4 cell count greater than 75 cells/mm3.

• Are at least 16 (need consent of parent or guardian if under 18).

• Are able to complete the study.

Exclusion Criteria

Patients will not be eligible for this study if they:

• Have ever taken anti-HIV medications.

• Are pregnant or breast-feeding.